Azitra (AZTR) vs Ensysce Biosciences (ENSC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ensysce Biosciences is the larger company by market cap ($8.9 million vs $8.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZTR | ENSC |
|---|---|---|
| Share price | $0.132 | $0.458 |
| Market cap | $8.00M | $8.91M |
| 1-day change | 0.00% | +6.66% |
| EPS (TTM) | $-0.28 | $-2.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.09 | $2.75 |
| 52-week low | $0.10 | $0.23 |
| Distance from 52-week high | -87.89% | -83.35% |
| Analyst consensus | buy | none |
| Avg. price target upside | +407.58% | +1701.31% |
| Average volume | 1.70M | 14.21M |
| Shares outstanding | 60.60M | 19.46M |
| Employees | 13 | 8 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Azitra
AZTR stock →Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S.
Healthcare · Biotechnology · 13 employees
About Ensysce Biosciences
ENSC stock →Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology.
Healthcare · Biotechnology · 8 employees
AZTR vs ENSC FAQ
Which is bigger, Azitra or Ensysce Biosciences?
Ensysce Biosciences (ENSC) is larger, with a market capitalization of $8.91M compared with $8.00M for Azitra (AZTR).
Are Azitra and Ensysce Biosciences in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.